Par Drugs & Chemical P/E Ratio
Par Drugs & Chemical (PAR) P/E ratio is 8.21 (Low), EPS (TTM) ₹10.86, current price ₹91.06 on NSE — Very Low - Potentially undervalued or facing challenges. For live price, revenue and the complete fundamental profile, see PAR stock live price.
Current P/E Ratio
8.21
Low Valuation
Very Low - Potentially undervalued or facing challenges
Current Valuation Metrics
P/E Ratio
8.21
Current Price
₹91.06
EPS (TTM)
₹10.86
Exchange
NSE
Valuation Signal
Signal
Undervalued
Sector Context
Sector Average
52.92
Sector Median
27.37
Sector Rank
#9 of 192
Sector Percentile
4.7%
PAR P/E Ratio — Valuation Signal & Historical Context
Par Drugs & Chemical P/E 8.21 — signal: Undervalued. Analyse Par Drugs & Chemical ownership structure to track promoter, FII and institutional holdings.
- Stock appears undervalued with PE of 8.21, suggesting potential buying opportunity
- Trading at discount to sector average PE of 52.92
PAR vs Healthcare Peers — P/E Ratio Comparison
Par Drugs & Chemical P/E 8.21 vs Healthcare average 52.92, median 27.37 — range 1.03–869.57.
Sector Average
52.92
Sector Median
27.37
Lowest P/E
1.03
Highest P/E
869.57
Companies
192
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Welcure Drugs & Pharmace… | WELCURE | 1.03 | ₹36 | Low |
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Phaarmasia | PHRMASI | 4.19 | ₹71 | Low |
| Ind Swift Laboratories | INDSWFTLAB | 4.7 | ₹1,105 | Low |
| Amwill Health Care | AMWILL | 6.85 | ₹71 | Low |
| Shelter Pharma | SHELTER | 7.0 | ₹50 | Low |
| Mono Pharmacare | MONOPHARMA | 7.1 | ₹23 | Low |
| Zenith Drugs | ZENITHDRUG | 7.69 | ₹74 | Low |
| Medicamen Organics | MEDIORG | 8.76 | ₹35 | Low |
| Galaxy Medicare | GML | 8.78 | ₹30 | Low |